Skip to main content

Latest stock market podcasts

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Morning Bell 10 November

Bell Direct
November 10, 2020

Morning Bell 9 November

Bell Direct
November 9, 2020

Weekly Wrap 6 November

Bell Direct
November 6, 2020

Morning Bell 6 November

Bell Direct
November 6, 2020

Morning Bell 5 November

Bell Direct
November 5, 2020

Morning Bell 4 November

Bell Direct
November 4, 2020

Morning Bell 3 November

Bell Direct
November 3, 2020

Morning Bell 2 November

Bell Direct
November 2, 2020

Weekly Wrap 30 October

Bell Direct
October 30, 2020

Morning Bell 30 October

Bell Direct
October 30, 2020

Morning Bell 29 October

Bell Direct
October 29, 2020